Safety and Efficacy of Sertraline for Depression in Patients with CHF (SADHART-CHF): A Randomized, Double-Blind, Placebo-Controlled Trial of Sertraline for Major Depression with Congestive Heart Failure

BACKGROUND: Sertraline, a selective serotonin-reuptake inhibitor (SSRI), has demonstrated substantial mood improvement in patients with post myocardial infarction or with unstable angina. The impact of sertraline on the prognosis and depression of patients with chronic heart failure (HF) and co-morb...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Jiang, Wei, O’Connor, Christopher, Silva, Susan G., Kuchibhatla, Maragatha, Cuffe, Michael S., Callwood, Dwayne D., Zakhary, Bosh, Henke, Elizabeth, Arias, Rebekka M, Krishnan, Ranga
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2008
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2659472/
https://ncbi.nlm.nih.gov/pubmed/18760123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2008.05.003
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi